← Evidence map

ReviewFrontiers in oncology2020

Targeting CXCR4 in AML and ALL.

Daniel Cancilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

64 papers cite itlatest 60 shown

2020
…
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33014834